Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Metacrine, Inc. | Chief Business Officer | Common Stock | 103K | $48.6K | $0.47 | Jan 26, 2023 | Direct |
PhaseBio Pharmaceuticals Inc | VP, Corporate Development | Common Stock | 7.06K | May 20, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MTCR | Metacrine, Inc. | Jan 26, 2023 | 1 | -$44.3K | 4 | Jan 27, 2023 | Chief Business Officer |
MTCR | Metacrine, Inc. | Feb 27, 2022 | 2 | $0 | 4 | Mar 1, 2022 | Chief Business Officer |
MTCR | Metacrine, Inc. | Feb 18, 2022 | 0 | $0 | 3 | Feb 24, 2022 | Chief Business Officer |
PHASQ | PhaseBio Pharmaceuticals Inc | May 20, 2021 | 1 | $8.11K | 4 | May 24, 2021 | VP, Corporate Development |